Australia markets closed

Organigram Holdings Inc. (OGI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5150-0.0250 (-1.62%)
As of 11:11AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close1.5400
Open1.5300
Bid1.5100 x 100
Ask1.5200 x 100
Day's range1.5100 - 1.5300
52-week range0.9700 - 2.9100
Volume79,721
Avg. volume1,581,559
Market cap156.446M
Beta (5Y monthly)1.07
PE ratio (TTM)N/A
EPS (TTM)-1.8300
Earnings date11 July 2024 - 15 July 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Organigram Signs Three Year Supply Agreement with Avida Medical in UK

    TORONTO, May 28, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce its second international medical cannabis customer in the UK, Avida Medical, a full-service medical cannabis and specials medicines manufacturing business.

  • Business Wire

    Organigram Reports Second Quarter Fiscal 2024 Results

    TORONTO, May 14, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the second quarter ended March 31, 2024 ("Q2 Fiscal 2024").

  • Business Wire

    Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024

    TORONTO, May 08, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter fiscal 2024 ended March 31, 2024, on Tuesday, May 14, 2024, prior to market open.